BioSolveIT 2008
Free Interactive Workshop on Virtual Screening and De Novo Design
June 5, 2008
Noordwijkerhout, The Netherlands
|
BioSolveIT is proud to host an interactive Workshop on Virtual Screening and De Novo Design on the 5th June 2008 immediately following the 8th International Conference on Chemical Structures in Noordwijkerhout, the Netherlands. The workshop will offer an occasion for expert computational chemists and novice modellers alike to learn how our software can help you in three major areas of drug discovery: Structure-Based, Ligand-Based, and De Novo Design. In particular, the workshop will cover the following topics:
|
Ligand Docking: The new, fully integrated FlexX 3.0 saves your time and gets you going. |
|
Scaffold Hopping by Design: Experience yourself that core replacement is now as simple as clicking ReCore. |
|
Similarity Searching Trillions of Compounds: Learn how Pfizer and others can retrieve leads by navigating through chemistry spaces with FTrees-FS. |
|
and of course the Pipeline Pilot interfaces, the MOE interface, combinatorial docking, … all on request |
Not only is the workshop free of charge but we'll also provide complimentary software for you to take home and continue to work with. The only two pre-requites are:
|
to register early (below) as space will be limited |
|
to bring your own laptop in order to make this a truly hands-on experience |
There is no need for any travel concerns either as BioSolveIT will provide an additional shuttle bus to the airport after the workshop for all those that need to make their way to the airport at the end of the day. The workshop will be held in English. Please note that the workshop is really meant to be interactive so the agenda may be subject to change.
|
| previous participants' comments |
|
"I believed that I was an expert. Now, I am not, but I know how to become a FlexX master."
"This is how a workshop should be."
|
| contact |
|
For further information please contact:
|
| * | Please note that BioSolveIT reserves the right to limit the number of multiple participants from one organization and to maintain a healthy balance of participants from academic and commercial institutions. |
|
